HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.

Abstract
Estrogen-receptor-negative breast cancer (BCER-) is mainly treated with chemotherapeutics. Leptin signaling can influence BCER- progression, but its effects on patient survival and chemoresistance are not well understood. We hypothesize that leptin signaling decreases the survival of BCER- patients by, in part, inducing the expression of chemoresistance-related genes. The correlation of expression of leptin receptor (OBR), leptin-targeted genes (CDK8, NANOG, and RBP-Jk), and breast cancer (BC) patient survival was determined from The Cancer Genome Atlas (TCGA) mRNA data. Leptin-induced expression of proliferation and chemoresistance-related molecules was investigated in triple-negative BC (TNBC) cells that respond differently to chemotherapeutics. Leptin-induced gene expression in TNBC was analyzed by RNA-Seq. The specificity of leptin effects was assessed using OBR inhibitors (shRNA and peptides). The results show that OBR and leptin-targeted gene expression are associated with lower survival of BCER- patients. Importantly, the co-expression of these genes was also associated with chemotherapy failure. Leptin signaling increased the expression of tumorigenesis and chemoresistance-related genes (ABCB1, WNT4, ADHFE1, TBC1D3, LL22NC03, RDH5, and ITGB3) and impaired chemotherapeutic effects in TNBC cells. OBR inhibition re-sensitized TNBC to chemotherapeutics. In conclusion, the co-expression of OBR and leptin-targeted genes may be used as a predictor of survival and drug resistance of BCER- patients. Targeting OBR signaling could improve chemotherapeutic efficacy.
AuthorsCrystal C Lipsey, Adriana Harbuzariu, Robert W Robey, Lyn M Huff, Michael M Gottesman, Ruben R Gonzalez-Perez
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 11 (May 27 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32471192 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin J Recombination Signal Sequence-Binding Protein
  • Leptin
  • NANOG protein, human
  • Nanog Homeobox Protein
  • Receptors, Estrogen
  • Receptors, Leptin
  • CDK8 protein, human
  • Cyclin-Dependent Kinase 8
Topics
  • Breast Neoplasms (drug therapy, genetics, metabolism)
  • Cell Line
  • Cell Line, Tumor
  • Cyclin-Dependent Kinase 8 (genetics, metabolism)
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Immunoglobulin J Recombination Signal Sequence-Binding Protein (genetics, metabolism)
  • Leptin (metabolism)
  • Nanog Homeobox Protein (genetics, metabolism)
  • Receptors, Estrogen (genetics)
  • Receptors, Leptin (genetics, metabolism)
  • Signal Transduction
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: